Page 8 - Williamh Rastetter News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Williamh rastetter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Williamh Rastetter Today - Breaking & Trending Today

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Position Cut by Fiera Capital Corp

Fiera Capital Corp reduced its holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Rating) by 0.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 372,519 shares of the company’s stock after selling 2,568 shares during the quarter. Fiera Capital Corp […] ....

United States , San Diego , Neurocrine Biosciences , Kevinc Gorman , Williamh Rastetter , Wyliew Vale , Russell Investments Group Ltd , Canaccord Genuity Group , Alliance Wealth Advisors , Fiera Capital Corp , Exchange Commission , Oppenheimer Co , Cantor Fitzgerald , Neurocrine Biosciences Inc , Securities Exchange Commission , Thrivent Financial For Lutherans , Get Rating , Capital Corp , Wealth Advisors , Investments Group , Arizona State Retirement System , State Retirement System , Director William , Neurocrine Biosciences Daily , Nasdaq Nbix , Sec Filings ,

TD Asset Management Inc Sells 99,494 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

TD Asset Management Inc reduced its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Rating) by 72.3% during the 4th quarter, HoldingsChannel.com reports. The firm owned 38,158 shares of the company’s stock after selling 99,494 shares during the quarter. TD Asset Management Inc’s holdings in Neurocrine Biosciences were worth $4,558,000 at the end […] ....

San Diego , United States , Williamh Rastetter , Neurocrine Biosciences , Kevinc Gorman , Wyliew Vale , Kevin Charles Gorman , Securities Exchange Commission , Cantor Fitzgerald , Canaccord Genuity Group , Congress Asset Management Co , Td Asset Management Inc , Vanguard Group Inc , York Mellon Corp , Bellevue Group , Neurocrine Biosciences Inc , Brown Advisory Inc , Management Inc , Get Rating , New York Mellon Corp , Asset Management , Brown Advisory , Director William , Exchange Commission , Charles Gorman , Visit Holdingschannel ,

Canandaigua National Corp Has $207,000 Stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

Canandaigua National Corp trimmed its stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Rating) by 8.3% during the 4th quarter, HoldingsChannel.com reports. The firm owned 1,735 shares of the company’s stock after selling 157 shares during the period. Canandaigua National Corp’s holdings in Neurocrine Biosciences were worth $207,000 as of its most recent filing with […] ....

San Diego , United States , Williamh Rastetter , Wyliew Vale , Kevinc Gorman , Eric Benevich , Neurocrine Biosciences , Bellevue Group , Wells Fargo Company , Neurocrine Biosciences Inc , Congress Asset Management Co , Securities Exchange Commission , Brown Advisory Inc , Exchange Commission , Vanguard Group Inc , Canandaigua National Corp , Morgan Stanley , Canaccord Genuity Group , York Mellon Corp , Get Rating , National Corp , New York Mellon Corp , Asset Management , Brown Advisory , Director William , Visit Holdingschannel ,

Neurocrine Biosciences, Inc. to Post Q1 2023 Earnings of $0.03 Per Share, Oppenheimer Forecasts (NASDAQ:NBIX)

Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Rating) – Research analysts at Oppenheimer issued their Q1 2023 earnings estimates for shares of Neurocrine Biosciences in a research report issued on Monday, May 1st. Oppenheimer analyst J. Olson anticipates that the company will post earnings of $0.03 per share for the quarter. The consensus estimate for Neurocrine […] ....

San Diego , United States , Williamh Rastetter , Neurocrine Biosciences , Neurocrine Bioscience , Wyliew Vale , Kevinc Gorman , Kevin Charles Gorman , Texas Permanent School Fund Corp , Neurocrine Biosciences Inc , Nisa Investment Advisors , Yousif Capital Management , Morgan Stanley , Wells Fargo Company , Daiwa Securities Group Inc , Fisher Asset Management , Get Rating , Biosciences Trading Down , Charles Gorman , Director William , Capital Management , Securities Group , Investment Advisors , Asset Management , Permanent School Fund Corp , Neurocrine Biosciences Daily ,

Brokers Set Expectations for Neurocrine Biosciences, Inc.'s FY2023 Earnings (NASDAQ:NBIX)

Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Rating) – Equities researchers at Cantor Fitzgerald issued their FY2023 earnings per share estimates for Neurocrine Biosciences in a report released on Thursday, April 27th. Cantor Fitzgerald analyst C. Duncan forecasts that the company will post earnings per share of $2.55 for the year. Cantor Fitzgerald has a “Overweight” […] ....

San Diego , United States , Williamh Rastetter , Kevinc Gorman , Wyliew Vale , Neurocrine Biosciences , Eiry Roberts , Neurocrine Bioscience , Bessemer Group Inc , Covestor Ltd , Securities Exchange Commission , Canaccord Genuity Group , Neurocrine Biosciences Company Profile , Cantor Fitzgerald , Neurocrine Biosciences Inc , Piershale Financial Group Inc , Acadian Asset Management , Get Rating , Asset Management , Financial Group , Director William , Exchange Commission , Neurocrine Biosciences Daily , Nasdaq Nbix , Earnings Estimates ,